Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)

NCT07056218 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07056218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07056218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
July 15, 2025
Completion date
December 15, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer